6
Participants
Start Date
February 21, 2022
Primary Completion Date
July 4, 2023
Study Completion Date
July 4, 2023
A:YH002+YH001
YH002 on CnD1,YH001 on CnD8,Q3W
B:YH002+YH001
YH002 and YH001 on same day,Q3W
YH002+YH001
A traditional 3+3 dose escalation algorithm
Macquarie University Hospital, Sydney
Orange Health Services, Orange
Cabrini Hospital Malvern, Malvern
Peninsula and South Eastern Haematology & Oncology Group, Frankston
Liaoning Cancer Hospital, Shenyang
Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai
Sir Run Run Shaw Hospital, Hangzhou
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Henan Tumor Hospital, Zhengzhou
Eucure (Beijing) Biopharma Co., Ltd
INDUSTRY